MENU
RNAC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cartesian Therapeutics (RNAC) Ownership - Who owns Cartesian Therapeutics?
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
704 Quince Orchard Road
Phone
+1 617 923-1400
Employees
38
Web
https://www.cartesiantherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
276.66M
P/E Ratio
1.98
Total Cash
160.32M
Projected Growth
N/A
Total Debt
13.35M
Revenue
1.03M
Risk (Beta)
0.60
Dividend Yield
N/A
Total Cash/Share
6.17
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
Fundamentals
RNAC
Capitalization
277M
P/E Ratio
1.98
Risk (Beta)
0.60
Dividend Yield
N/A
Total Cash
160M
Total Cash/Share
6.17
Total Debt
13.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.04%
Revenue
1.03M
ROE
N/A
Book Value
-2.53M
P/B Ratio
588.24
Cash Flow
N/A
Earnings
-0.67
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
13.33
Current Revenue Per Employee
4515.15
Dividends Per Share - Security
N/A
EBITDA
-118.73M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-9.84
Shares Held By Institutions
128M
Shares Outstanding - Current
26M
Total Liabilities
391M
Total Volume MTD
N/A
Value
-1
Gain YTD
-44.165
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
a developer of targeted immunotherapies and vaccines to treat and prevent diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
704 Quince Orchard Road
Phone
+1 617 923-1400
Employees
38
Web
https://www.cartesiantherapeutics.com